- A state board of pharmacy is developing policy on whether pharmacy interns may verify final product checks. Which analysis BEST supports limiting this authority?
Answer: Final verification is a pharmacist-only function under most state practice acts; interns work under supervision and have not obtained licensure
Final product verification is typically reserved for licensed pharmacists under state pharmacy practice acts. Interns are in training under a licensed pharmacist's supervision and have not completed the licensing process. Passing the NAPLEX does not confer a license; licensure requires both passing the exam and board approval. DEA registration for interns, where applicable, covers only supervised dispensing, not independent final verification authority.
- A pharmacist is licensed in State A and wants to provide telepharmacy services to patients located in State B. What licensure is most likely required?
Answer: The pharmacist likely needs a State B license or non-resident pharmacy permit covering the telepharmacy activity in State B
Telepharmacy services directed to patients in another state are subject to that state's pharmacy practice laws. Most states require the dispensing pharmacist or pharmacy to hold a license or non-resident permit in the state where the patient is located. The Ryan Haight Act governs telemedicine prescribing of controlled substances but does not create a federal pharmacist telemedicine license. DEA registration for controlled substances is a separate matter.
- A pharmacist's license is placed on probation by the state board due to a medication error. During the probationary period, which statement is most accurate?
Answer: The pharmacist may continue practicing subject to conditions imposed by the board
Probation is a disciplinary action that allows continued practice under specified conditions - such as supervision requirements, additional CE, or practice restrictions - set by the board. It is not an automatic revocation or suspension. DEA registration is not automatically revoked by state probation; a separate DEA action would be required. The employing pharmacy does not need to be on probation for the individual to continue working.
- What is the proper procedure for the PIC to grant this authority to the staff pharmacist?
Answer: The PIC must execute a Power of Attorney (POA) form, which is then filed at the pharmacy and made readily retrievable.
Federal regulations allow a DEA registrant to delegate the authority to order controlled substances to other individuals via a Power of Attorney (POA). The POA must be signed by the registrant, the individual being granted authority, and two witnesses. It does not need to be submitted to the DEA but must be maintained on-site with other DEA records and be available for inspection.
- A pharmacy receives notice that its DEA registration will expire in 30 days. What must the pharmacy do to continue dispensing controlled substances without interruption?
Answer: Submit a DEA Form 224a (renewal application) before the expiration date
To renew a DEA registration, a pharmacy submits DEA Form 224a - the renewal application. If the renewal is submitted before the expiration date, the pharmacy may continue operating under the existing registration until the DEA acts on the renewal. DEA Form 224 is for new (initial) applications, not renewals. State board notification is not required for DEA renewal. Inventory transfer is not required to maintain legal possession during a timely renewal process.
- The DEA registration for a community pharmacy is set to expire in 45 days. What is the correct procedure for renewing this registration?
Answer: The pharmacy registrant must complete and submit DEA Form 224a online or by mail before the expiration date.
A pharmacy's (dispenser's) DEA registration must be renewed every three years using DEA Form 224a. The registrant is responsible for initiating this process. It is not automatic (C). The DEA sends a renewal notice, but the ultimate responsibility for timely renewal lies with the registrant. DEA Form 222 (D) is for ordering Schedule II substances, not registration renewal. Ceasing ordering (A) is unnecessary if the renewal is submitted on time.
- A pharmacist's license has been expired for 14 months. She wants to return to practice. What is the most likely requirement before she can legally dispense prescriptions again?
Answer: She must apply for license renewal and likely complete continuing education requirements before reinstatement
An expired license renders a pharmacist ineligible to practice. Reinstatement typically requires completing an application, paying applicable fees, and demonstrating continuing education completion. Retaking the NAPLEX is generally required only when a license has been lapsed for an extended period (varies by state). DEA registration is separate from state licensure and does not drive the ability to dispense non-controlled prescriptions.
- Which federal agency is responsible for issuing DEA registration to pharmacies that dispense controlled substances?
Answer: The Drug Enforcement Administration (DEA)
The DEA, under the Department of Justice, is the federal agency that issues DEA registrations (DEA Form 224) to pharmacies authorizing them to handle controlled substances. The FDA regulates drug products, CMS oversees Medicare/Medicaid reimbursement, and HHS is a broad umbrella department - none issue DEA registration.
- A pharmacy wants to add sterile compounding services. Beyond standard pharmacy licensure, what is most likely required?
Answer: State board of pharmacy permit for sterile compounding operations.
Many states require pharmacies performing sterile compounding to obtain an additional state board permit or approval beyond the standard pharmacy license, reflecting the heightened patient safety risks of sterile operations. This is a legal requirement in those jurisdictions, distinct from any third-party accreditation program. Third-party accreditation (such as PCAB) may be required by health plans or payers as a condition of contracting but is not a universally mandated legal requirement. C correctly identifies the state board approval pathway as what is most likely legally required. A is incorrect because DEA registration relates to controlled substance handling, not to sterile compounding operations generally. B is incorrect because FDA Center for Drug Evaluation and Research does not issue waivers authorizing pharmacy sterile compounding. D is incorrect because 503B registration is required for outsourcing facilities compounding without patient-specific prescriptions for distribution to healthcare facilities, not for all pharmacies that perform sterile compounding.
- A community pharmacy occasionally sells small quantities of non-controlled, prepackaged drugs to a local physician's office for office use. Under federal law, the pharmacy must obtain a wholesale distributor license if the total annual dollar value of such sales exceeds what threshold?
Answer: 5% of the pharmacy's total annual prescription drug sales revenue.
Federal law, particularly the Drug Supply Chain Security Act (DSCSA), contains a provision commonly known as the "5% rule." A pharmacy is exempt from registering as a wholesale distributor as long as its total distribution sales to licensed practitioners for office use do not exceed 5% of its total annual prescription drug sales revenue. If this threshold is crossed, the pharmacy must obtain a wholesale distributor license.
- An established community pharmacy plans to move its operations to a new building directly across the street. Which action concerning licensure is most likely required before dispensing can begin at the new address?
Answer: Obtain a new state pharmacy license and a new DEA registration for the new physical address.
Both state pharmacy licenses and DEA registrations are issued for a specific physical location and are non-transferable. When a pharmacy relocates, even to a location next door, it is considered a new facility from a regulatory perspective. The pharmacy must apply for a new state license and a new DEA registration for the new address before any dispensing activities can legally occur there.
- A pharmacist licensed in State X relocates and wants to apply for licensure in State Y via reciprocity. State Y requires applicants to pass the MPJE for State Y's law. The pharmacist has never taken the MPJE for State Y. What must she do?
Answer: She must pass State Y's MPJE as a condition of licensure, even when applying by reciprocity or endorsement
Many states require applicants applying by reciprocity or endorsement to pass the state-specific MPJE (or a state law exam) because the exam tests that state's pharmacy jurisprudence. An existing license from another state satisfies the NAPLEX requirement in most cases, but the MPJE requirement is state-specific and generally cannot be waived based on years of experience. Requirements vary by state, but the MPJE for the receiving state is commonly required.
- The owner of "Smith's Pharmacy," an independent community pharmacy, sells the business to a large retail chain corporation. What licensure action must be taken for the pharmacy to continue operating under the new ownership?
Answer: The new corporate owner must apply for and obtain a new state pharmacy license and a new DEA registration.
State pharmacy permits and DEA registrations are issued to a specific owner at a specific location and are non-transferable. When a pharmacy is sold, the new owner must obtain their own permit and registration before taking control of the business. The previous owner's credentials become void with the change in ownership, and a simple notification is insufficient.
- A certified pharmacy technician's state registration is due for renewal. In most jurisdictions, which of the following is a primary requirement for the technician to be eligible to renew their registration?
Answer: Completion of a specified number of continuing education hours relevant to pharmacy practice.
Similar to pharmacists, most state boards of pharmacy mandate that registered or certified pharmacy technicians complete a specific number of continuing education (CE) credits during each renewal period. This ensures they maintain competency and stay current with practice standards. A new background check (B) is more common for initial registration. A letter of recommendation (C) is not a standard renewal requirement. A competency exam (D) is an internal employment requirement, not a state registration requirement.
- A new hospital is preparing to open its inpatient pharmacy. The pharmacy will provide sterile compounding services and dispense controlled substances to patients within the hospital. At a minimum, which licenses/registrations must the pharmacy department secure to operate legally?
Answer: A state-issued institutional pharmacy permit and a facility-specific DEA registration.
The core requirements for a hospital pharmacy are a state license specific to its type of practice (institutional) and a DEA registration for the facility to handle controlled substances. Individual pharmacists do not need their own DEA numbers (A) to dispense under the hospital's registration. FDA registration (C) is for 503B outsourcing facilities, not standard hospital pharmacies. NABP accreditation (D) is voluntary, and wholesale licenses are for distribution, not dispensing.
- A pharmacy is relocating to a new address. The Pharmacist-in-Charge has already applied for and received a new state pharmacy license for the new location. Which action must be taken regarding the pharmacy's DEA registration?
Answer: Apply for a new DEA registration for the new location, as existing registrations are site-specific and non-transferable.
DEA registrations are specific to a single physical location and cannot be transferred or have their address changed. When a pharmacy moves, it must apply for a new DEA registration for the new address. A simple request for modification is not sufficient, and state board actions do not alter federal registration requirements.
- A pharmacist is employed as a "floater" for a large chain and works at 15 different pharmacies, all owned by the same corporation within the same state. Each pharmacy has its own DEA registration. The pharmacist does not have their own personal DEA number. Is this arrangement permissible for dispensing controlled substances?
Answer: Yes, a licensed pharmacist can dispense controlled substances under the authority of the pharmacy's DEA registration where they are practicing.
A pharmacist's authority to dispense controlled substances is derived from their state license and their role as an agent of a DEA-registered pharmacy. Individual staff pharmacists do not need their own DEA registration to dispense. Power of Attorney (C) is for ordering, not dispensing. There is no such credential as a "floater" DEA registration (D).
- A pharmacy manager discovers that one of her pharmacists has been practicing on a lapsed license for three months. What is the manager's BEST course of action?
Answer: Remove the pharmacist from dispensing duties immediately; consult with legal counsel and consider self-reporting to the state board
Practicing pharmacy on a lapsed license constitutes unauthorized practice, which exposes both the pharmacist and the pharmacy to disciplinary action. The manager's correct response is to stop the illegal practice immediately, seek legal guidance, and consider proactive self-disclosure to the state board. Allowing continued practice compounds the violation. Backdating an application is fraudulent. The FDA has no jurisdiction over individual pharmacist licensure compliance.
- A state board proposes a rule requiring all pharmacists to complete 2 hours of opioid-specific CE per renewal cycle. A pharmacy association challenges this as overreach. Which argument BEST supports the board's authority?
Answer: State boards can mandate CE topics to ensure public health and safety.
State boards of pharmacy derive their authority from state pharmacy practice acts, which broadly empower boards to establish CE requirements for license renewal. Targeted CE requirements on topics like opioid safety are a recognized exercise of this authority. Neither the FDA nor the Ryan Haight Act mandates pharmacist CE. State boards routinely require topic-specific CE (e.g., HIV counseling, controlled substances) without exceeding their statutory authority.
- A community pharmacy hires a new employee with no prior pharmacy experience to work as a technician. What type of license or registration do many states require this individual to obtain before they can begin performing technician duties?
Answer: A technician-in-training or technician trainee registration from the state board of pharmacy.
To allow individuals to work and gain experience before becoming fully certified, many states have a "technician-in-training" registration. This is a preliminary, often time-limited credential that allows an individual to perform technician duties under supervision while completing required training. National certification (A) is typically the next step, not the first. An intern license (B) is for pharmacy students enrolled in accredited programs.
